Ocular immune privilege
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The eye attempts to limit local immune and inflammatory responses to preserve vision. This phenomenon, known as ocular immune privilege, is mediated by a combination of local and systemic mechanisms. While immune privilege is believed to protect the eye from day-to-day inflammatory insults, it is not absolute and its mechanisms are still incompletely understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The small size, accessibility, confined structure, and immune-privileged status of the eye [74, 75], make it an ideal target for gene therapy”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“it has been shown that the eye exhibits physical barriers (e.g., blood-retina-barrier preventing free entry of systemic immune cells) as well as cell-bound and soluble immunosuppressive factors11,12.”
From Investigation of Cas9 Antibodies in the Human Eye (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · cited 1×
“that have recovered fromexperimental autoimmuneuveitis (EAU) contain regulatory activity, whose generation is dependent on the presence of eye [7-9].”
BackgroundOcular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
DeVoss, J., Hou, Y., Johannes, K., Lu, W., Liou, G. I., Rinn, J., Chang, H., Caspi, R. R., Fong, L., & Anderson, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061864 · Cited by 275
Self-citationSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218 · cited 1×
“It involvesmigration from the eye to the spleen of F4/80 antigen-presenting cells that interact with invariant natural killer T cells and B cells and culminates in elicitation of systemic regulatory immunity through induction of CD4 afferent and CD8 efferent Treg cells (reviewed in [4,6]).”
BackgroundOcular autoimmunity: the price of privilege?
Caspi, R. R. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00439.x · Cited by 162
Self-citationOcular Immunosuppressive Microenvironment
Taylor, A. W. (2007) · KARGER eBooks · doi:10.1159/000099255 · Cited by 160
Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells,
Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7525 · Cited by 126
Organ-Resident, Nonlymphoid Cells Suppress Proliferation of Autoimmune T-Helper Lymphocytes
Caspi, R. R., ROBERGE, F. G., & Nussenblatt, R. B. (1987) · Science · doi:10.1126/science.2956685 · Cited by 123
Self-citationSugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., & Mochizuki, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2846 · Cited by 99
Cited by
Items 201–269 of 269
Nóbrega, C., Mendonça, L. S., & Matos, C. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-41333-0_9 · Cited by 1
Evangelho, K. D. S., de‐la‐Torre, A., Salguero, G., Ramírez-Santana, C., Téllez-Conti, C., Cañas-Arboleda, M., Cifuentes‐González, C., Rojas-Carabali, W. A., & Vivero, C. D. (2024) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2024.132 · Cited by 1
Neroeva, N. V., Balatskaya, N. V., Brilliantova, A. G., Катаргина, Л. А., Kharitonov, A. E., Lagarkova, M. A., & Bogomazova, A. N. (2024) · Ophthalmology in Russia · doi:10.18008/1816-5095-2024-1-193-204 · Cited by 1
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma
Lakshmi, P. K., Pawar, R. S., Katare, Y. K., & Sudheesh, M. S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00583 · Cited by 1
Bilateral optic neuropathy in Krukenberg tumor treated with FOLFOX plus nivolumab: a case report
Lee, J., Choi, J., Kang, M. S., Yu, S., & Kim, K. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-04102-y · Cited by 1
Lim, S. T., Kiew, S. Y., Toh, L. Z., Chu, S. W. L., Zanardi, M., Deng, Q., Wang, X., & Wong, T. T. L. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110735 · Cited by 1
Pulman, J., Ren, D., Visticot, L., Malki, H., Yao, Y., Cian, A. D., Ail, D., Concordet, J., Dalkara, D., & Fisson, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693665 · Cited by 2
Willmington, C., Kirby, A., & Murphy, A. (2025) · Health Economics Review · doi:10.1186/s13561-025-00707-7
“The small size, accessibility, confined structure, and immune-privileged status of the eye [74, 75], make it an ideal target for gene therapy, which in turn is less likely to cause excessive inflammatory and immune responses when delivered to this organ [76].”
Tumor Heterogeneity in Uveal Melanomas
Mensink, H. W. (2010) · EUR Research Repository (Erasmus University Rotterdam)
Papotto, P. H. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2014.tde-14032015-101012
Localized Tolerance and Development of an Alternative Transplant Site to Treat Type 1 Diabetes
Skoumal, M. (2017) · Deep Blue (University of Michigan)
A systemically-delivered stem cell therapy for dry age related macular degeneration
Pay, S. L. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2006q
Skottman, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-28384-1_14 · Cited by 1
Novel therapeutic targets in uveitis
Tempest-Roe, S. (2017) · Spiral (Imperial College London) · doi:10.25560/75500
Gene Therapy and Surgery for Retinal Diseases
Jiang, D. J., Xu, C. L., & Tsang, S. H. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0027221
Commensals Modulate Innate Immune Response Through L-Plastin to Bacterial Keratitis
Smith-Page, K. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Iris Immunology and Wound Healing
Moazed, K. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-45756-3_6
Pseudomonas Aeruginosa Inducing Nociception Increases Susceptibility to Bacterial Keratitis
Lin, T. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Silva, E. C. D. (2020) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Wu, J. (2021) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-30689
Vitamin D3 production by ocular barrier epithelial cells
Al-Salem, J. A. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Regulation of Immune Responses
Maleki, A., Manhapra, A., Mousa, H. M., & Foster, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_332-1
Regulation of Immune Responses
Maleki, A., Manhapra, A., Mousa, H. M., & Foster, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_332
Marmalidou, A., & Nwanze, C. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-09126-6_37
Laura Donaldson, P.-5., Matthew D. Benson, P.-4., Aishwarya Sundaram, P.-4., Gareth D. Mercer, P.-3., & Jenny Qian, P.-1. (2020) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2020.04.024
Kimbrel, E. A., & Lanza, R. (2020) · Principles of Tissue Engineering · doi:10.1016/b978-0-12-818422-6.00064-2
Extra Visual Function of the Human Eye.
(2020) · doi:10.46940/cjoec.02.1003 · Cited by 1
Wollanke, B., & Gerhards, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104527
Posibilidad de terapia génica en pacientes con enfermedades retinianas hereditarias
Bofill, A., Oporto, J. I., Verdaguer, J. I., López, J. P., Acuña, O., Iturriaga, H., Ossandón, D., & Zanolli, M. (2022) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2022.10.002
Possibility of genetic therapy for inherited retinal conditions
Bofill, A., Oporto, J. I., Verdaguer, J. I., López, J. P., Acuña, O., Iturriaga, H., Ossandón, D., & Zanolli, M. (2022) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2022.10.004
Sun, M. M., & Gordon, L. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00074-5
Microbiome abnormalities and retinal disease
Barr, L. C., Hazari, H., & Rullo, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98338-9.00010-4
An Algorithmic Approach to Diagnosis in Patients with Ocular Surface Discomfort
Ambati, D., & Rao, S. K. (2023) · TNOA Journal of Ophthalmic Science and Research · doi:10.4103/tjosr.tjosr_114_23
Neroeva, N. V., Balatskaya, N. V., Катаргина, Л. А., & Brilliantova, A. G. (2023) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2023-16-4-152-158 · Cited by 1
Skottman, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-35055-9_14
Goblirsch, T. J., Huang, V., Maguire, A. M., & Chebolu, A. P. (2024) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000001558
Nakai, Y., Jin, J., Ogawa, T., Sakai, N., Maeda, A., Hironaka, K., Fukuda, M., Danno, H., Tanaka, Y., Hori, S., et al. (2024) · eLife · doi:10.7554/elife.92510.2.sa3
Gene Therapy for Neurodegeneration in Glaucoma
Karl, J. J., & Tseng, H. C. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_21
Microbiome and T Cells in Glaucoma
Tang, Y., Prendergast, L. C., & Chen, D. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00096-7
Neroeva, N. V., Balatskaya, N. V., Neroev, V. V., Brilliantova, A. G., Катаргина, Л. А., & Lagarkova, M. A. (2024) · Russian Journal of Immunology · doi:10.46235/1028-7221-16700-doc
A calcium channel α2δ subunit theory of amyotrophic lateral sclerosis and frontotemporal dementia
Rappoport, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-345008-2.00015-1
Pembrolizumab-Induced Optic Neuritis: A Case Report
Miruliya, M. (2025) · Journal of Public and Clinical Health Research · doi:10.63486/jpchr.25060101
Feng, Y., & Dana, R. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000571
Sadanandan, S., Brennan, M., & Schmoll, C. (2025) · Paediatrics and Child Health · doi:10.1016/j.paed.2025.09.002
A Single Cell Atlas of the Newt Iris During Lens RegenerationPreprint
Williams, O. M., Ahearn, K. E., Sevigny, J. L., Farber, N., Hegde, D., Lampel, K. J., Loporcaro, J., Napoleon, L., Nipoti, J., Ralich, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.06.692619
Shi, H., Koronyo, Y., Fuchs, D.-T., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Figshare · doi:10.6084/m9.figshare.13279800
Étude de la réponse immunitaire au cours d’une toxoplasmose oculaire dans des modèles murins
Rochet, E. (2014) · theses.fr (ABES) · doi:10.70675/acbd5418z9b92z4269z9c6fz39aebdc04419
Implants à base de PLGA pour la libération oculaire
Bode, C. (2019) · theses.fr (ABES) · doi:10.70675/db064711z80cez456aza9edzb4509e94b78b
Müller Cells and Retinal Regeneration : The Role of the Hippo/YAP Signaling Pathway
García-García, D. (2020) · theses.fr (ABES) · doi:10.70675/8f64fd35z11c5z460fz8f49zb8e5b4e5e304
de Malglaive, F. (2023) · theses.fr (ABES) · doi:10.70675/06851042zfd98z4309za439z2c71e1f19fcb · Cited by 1
Bonneau, N. (2024) · theses.fr (ABES) · doi:10.70675/601f0632zbb49z4605z8578zad0bb870e560
Alvarez, N., Bennitt, A., & Miller, L. (2026) · Springer eBooks · doi:10.1007/978-3-032-19116-8_21
Johnson, E., Kaffash, E., Sheini, F., Rennhack, A., Sielski, M. S., Zhylkibayev, A. A., Calzi, S. L., Poudel, S., Atigadda, V. R., Xu, Q., et al. (2026) · Diabetes · doi:10.2337/db26-0053
Kanno, S., Yamashita, M., Sato, K., & Nakazawa, T. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00694
Gundu, A., Holt, H., & Ostrovsky, A. (2026) · Cureus · doi:10.7759/cureus.115030
Interferon-mediated regulation of the neurovascular unit in diabetic retinopathy
Yu, H., Xie, L., & Lin, W. (2026) · Inflammation Research · doi:10.1007/s00011-026-02369-5
Quantitative Model of the Ocular Immune Response during Seasonal Allergic ConjunctivitisPreprint
Gunputh, N. D., Maki, K. L., Carichino, L., & Woeller, C. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.21.753366
Dommeti, S., & Seetharam, G. U. D. E. (2026) · Public Health - Open Journal · doi:10.17140/phoj.2026.v11.i01.pp531-559.2643
Samalia, P. D., Sims, J. L., Lindsay, K., & Niederer, R. L. (2026) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2026.2751017
Investigating the Microbiome of the Eye and the Potential of Probiotic Use in Optometry
Hartgerink, R. (2023) · DigitalCommons@UNO
Elevated Intraocular Pressure Facilitates T-Cell–Mediated Retinal Ganglion Cell Loss
Mayberry, J. E., Xian, S., Roy, S., & Kuehn, M. H. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.12.68
Metadata
- Authors
- Zhou, R., & Caspi, R. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caspi, Rachel R
- Venue
- F1000 Biology Reports
- Publisher
- H1 Connect
- Published
- 2010-01-18
- Volume
- 2
- ISSN
- 1757-594X (ISSN-L)
- DOI
- 10.3410/b2-3
- PMC
- PMC2948372
- OpenAlex
- W2132060134
- Cited by
- 259
- References
- 18
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 32 · 2023: 23 · 2022: 31 · 2021: 23 · 2020: 31 · 2019: 14 · 2018: 22 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000 Biology Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- ocular immune privilege, eye, inflammation, vision preservation, local immune regulation, ocular immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.